Meet Our Staff
We are pleased to introduce the ATHN staff—the people who are working every day to help ATHN achieve our goals and realize our mission. At ATHN, we all share a commitment to securing data, advancing knowledge, and transforming care for the bleeding and clotting disorders community.
Crystal Watson, ATHN's President and CEO has over 25 years of experience working in the blood disorders community in both government and nonprofit organizations. Since joining ATHN in 2008, Crystal has successfully championed the evolution of the technology and infrastructure underpinning the national database now being used to support research and surveillance.
Prior to joining ATHN, Crystal was with the CDC in the Division of Blood Disorders and the National Center for Public Health Informatics and spent 10-years with Hemophilia of Georgia. She has a Bachelor of Science degree in Social Work from the University of North Carolina.
Before joining ATHN, Linda Magliocco was the director of finance and CFO at the Mary M. Gooley Hemophilia Center in Rochester, New York for 26 years. She began working with ATHN in2006 as a volunteer helping with bookkeeping. She was invited to come on board full time as our finance director in 2013 and now serves as Vice President of Finance and Administration.
Moses Miles is the Chief Operating Officer of the American Thrombosis and Hemostasis Network. In this role he is responsible for the day-to-day activities of the organization and ensuring the execution of ATHN’s mission. He has more than 30 years’ experience in information and healthcare technology in commercial, US federal and US state environments. Moses is a former Senior Manager of Deloitte Consulting and the former Chief Architect of the State of Georgia where he was responsible for setting technology policy and standards for the state’s agencies.
Michael Niekamp is responsible for ATHN’s finance and human resource functions. He brings more than 20 years of experience in financial leadership in the nonprofit healthcare space, including senior leadership roles with the Lung Cancer Research Foundation, Cohen Veterans Network, National Multiple Sclerosis Society, and The Leukemia & Lymphoma Society. Michael is a graduate of Siena College in Loudonville, NY.
As Chief Science Officer (CSO) for ATHN, Michael Recht, MD, PhD, MBA, works at the strategic and policy level to inform the scientific direction of ATHN. He works across the organization to define, develop, and implement ATHN’s science and research strategy.
As a pediatric hematologist, Dr. Recht has actively participated in over 110 clinical trials testing new treatments for children, adolescents, and adults with bleeding and clotting disorders, including leading research involving gene therapy for hemophilia. Dr. Recht also continues to treat children, adolescents, and young adults affected by bleeding and clotting disorders as a member of the Hemophilia Treatment Center at Yale University School of Medicine.
For more information, contact ATHN at firstname.lastname@example.org.